You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patients’ characteristics summary

From: RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

Characteristics   Patients (n = 114)
Age   63 (29,83)
Sex Male 81 71.1
Female 33 28.9
KRAS mutation Mutated 35 30.7
Wild type 79 69.3
BRAF mutation Mutated 3 2.6
Wild type 111 97.4
Tumor side Left 89 78.1
Right 25 21.9
Chemotherapy Neoadjuvant 78 68.4
adjuvant 30 26.3
None 6 5.2
Type of Chemotherapy FOLFOX 47 60
FOLFOX anti VEGF 18 23
FOLFOX anti EGFR 11 14
Other 2 3
Other 45 57.7